SLC43A2 and acute myeloid leukemia: However, there are no direct reports of HNMT, TFEB, SDSL, SLC43A2, and SFXN3 in AML, and this study was the first to report that HNMT, TFEB, SDSL, SLC43A2, and SFXN3 were related to the prognosis of AML.